Radioligand Therapies (RLT) Associate Director, Priority Accounts – Kentucky/Tennessee/South Carolina
Novartis
Summary
This is a field-based and remote opportunity supporting key accounts in an assigned geography. As a Radioligand Therapies (RLT) Associate Director, Priority Accounts, you'll partner with Neuroendocrine Tumors (NET) Centers of Excellence and health care system sites to drive impactful engagement. This role focuses on creating and executing strategic business plans for key accounts while collaborating with cross-functional teams to deliver institution-centric programs aligned with business priorities and compliance standards.
Job description
Key Responsibilities
- Champion institutional advocacy for the adoption of the Radioligand Therapies (RLT) and Neuroendocrine Tumors (NET) brand to support appropriate product utilization.
- Build strong partnerships with Neuroendocrine Tumors Centers of Excellence and health care system sites to drive impactful engagement.
- Develop, coordinate, and execute strategic business plans for priority accounts, ensuring alignment with market dynamics and organizational goals.
- Cultivate relationships with clinical, operational, and administrative decision-makers; and support their efforts to streamline care pathways, treatment protocols and workflow solutions to enable patient access.
- Stay informed on market trends, customer economics, and access models, including payment programs and reimbursement strategies.
- Compliantly share knowledge of Novartis' offerings and ensure account administrators have access to relevant resources, while maintaining compliance.
- Collaborate with local teams to create tailored, institution-specific plans that reflect local market forces and opportunities.
- Educate clinicians, staff and other institutional stakeholders on disease state and/or product information as appropriate to support institutional adoption of Radioligand Therapies (RLT) and development of relevant treatment pathways and protocols.
- Develop a clear understanding of customer needs across the ecosystem – from departments to executive leadership. Use insights to anticipate trends, shape priorities, and deliver impactful outcomes.
- Support team members in diagnosing business challenges and implementing strategies that optimize outcomes for Radioligand Therapies and Neuroendocrine Tumors accounts and affiliated health systems.
Essential Requirements
- Bachelor's degree required from 4-year college or university.
- 8+ years' experience in pharmaceutical, biotech, healthcare, or similarly structured industries with large, geographically dispersed field teams.
- 2+ years' experience in project management and translation of strategy into execution.
- 3+ years' experience managing complex accounts, including large academic centers and hospitals, with demonstrated success in strategic account management.
- Recent US experience (within last 5 years) with deep understanding of US healthcare ecosystems.
- Demonstrated deep customer and cross-functional knowledge, healthcare ecosystem thinking, with strong business acumen and technology/digital engagement proficiency.
- Robust business background, with strong ability to collaborate and work cross-functionally in a matrix environment to build effective strategic account plans aligned to customer and organization goals.
- Candidate must reside within territory or reside in a territory adjacent to the assigned geography.
- Ability to travel 60-80% over a broad geography is required, with the ability to drive and/or fly within the territory.
- Must have a valid driver's license.
Desirable Requirements
- Strong knowledge of the Radioligand Therapies (RLT) platform and experience representing Radioligand Therapies products, with a proven ability to drive adoption at scale.
- Cross-functional experience in areas such as Marketing, Medical, Market Access, Reimbursement, or Sales Leadership, and prior engagement with assigned accounts.
Requirements
- Bachelor's degree required from 4-year college or university
- 8+ years' experience in pharmaceutical, biotech, healthcare, or similarly structured industries with large, geographically dispersed field teams
- 2+ years' experience in project management and translation of strategy into execution
- 3+ years' experience managing complex accounts, including large academic centers and hospitals, with demonstrated success in strategic account management
- Recent US experience (within last 5 years) with deep understanding of US healthcare ecosystems
- Demonstrated deep customer and cross-functional knowledge, healthcare ecosystem thinking, with strong business acumen and technology/digital engagement proficiency
- Robust business background, with strong ability to collaborate and work cross-functionally in a matrix environment to build effective strategic account plans aligned to customer and organization goals
- Candidate must reside within territory or reside in a territory adjacent to the assigned geography
- Ability to travel 60-80% over a broad geography is required, with the ability to drive and/or fly within the territory
- Must have a valid driver's license
Benefits
- Health benefits
- Life insurance
- Disability benefits
- 401(k) with company contribution and match
- Paid time off
- Vacation
- Personal days
- Holidays
- Performance-based cash incentive
- Annual equity awards
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.